To include your compound in the COVID-19 Resource Center, submit it here.

FDA approves Pfizer's Mylotarg for AML

On Friday, FDA approved a BLA from Pfizer Inc. (NYSE:PFE) for Mylotarg gemtuzumab ozogamicin to treat adults with newly diagnosed, CD33-positive acute myelogenous leukemia and for

Read the full 264 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE